Demarest; Keith T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Demarest; Keith T..The latest application filed is for "gpr40 agonists in anti-diabetic drug combinations".

Company Profile

1.18.30

Demarest; Keith T. - Flemington NJ
Demarest; Keith T - Flemington NJ
Demarest; Keith T. - Fleminton NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
GPR40 agonists in anti-diabetic drug combinations Grant 10,195,178 - Liang , et al. Fe	2019-02-05
Gpr40 Agonists In Anti-diabetic Drug Combinations App 20170290800 - Liang; Yin ; et al.	2017-10-12
Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol Grant 8,633,184 - Kuo , et al. January 21, 2	2014-01-21
Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators Grant 8,278,268 - Bussolari , et al. October 2, 2	2012-10-02
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs Grant 8,242,173 - DeAngelis , et al. August 14, 2	2012-08-14
Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators Grant 8,183,213 - Bussolari , et al. May 22, 2	2012-05-22
Methods of using alpha-methylglucoside (AMG) as an indicator for glucose absorption and excretion Grant 8,147,801 - Demarest , et al. April 3, 2	2012-04-03
3,4-dihydro-2H-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors Grant 8,012,963 - Kuo , et al. September 6, 2	2011-09-06
1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors Grant 7,928,238 - Rano , et al. April 19, 2	2011-04-19
Use Of Alpha-methylglucoside (amg) As An Indicator For Glucose Absorption And Excretion App 20110065200 - Demarest; Keith T. ; et al.	2011-03-17
4-((phenoxyalkyl)thio)-phenoxyacetic Acids And Analogs App 20100331406 - DEANGELIS; Alan ; et al.	2010-12-30
Substituted spiroheterocycles Grant 7,825,111 - Xiang , et al. November 2, 2	2010-11-02
Substituted spiroheterocycles Grant 7,825,110 - Xiang , et al. November 2, 2	2010-11-02
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs Grant 7,812,053 - DeAngelis , et al. October 12, 2	2010-10-12
3,4-dihydro-2h-benzo[1,4]oxazine And Thiazine Derivatives As Cetp Inhibitors App 20100227857 - Kuo; Gee-Hong ; et al.	2010-09-09
3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors Grant 7,749,995 - Kuo , et al. July 6, 2	2010-07-06
Benzoazepin-oxy-acetic Acid Derivatives As Ppar-delta Agonists Used For The Increase Of Hdl-c, Lower Ldl-c And Lower Cholesterol App 20100120748 - Kuo; Gee-Hong ; et al.	2010-05-13
Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol Grant 7,678,786 - Kuo , et al. March 16, 2	2010-03-16
Combination Therapy Comprising Glucose Reabsorption Inhibitors And Retinoid-x Receptor Modulators App 20090075864 - Bussolari; Jacqueline C. ; et al.	2009-03-19
Combination Therapy Comprising Glucose Reabsorption Inhibitors And Ppar Modulators App 20080096802 - Bussolari; JACQUELINE C. ; et al.	2008-04-24
Methods of using substituted tetralins and indanes Grant 7,351,857 - Chen , et al. April 1, 2	2008-04-01
Substituted Spiroheterocycles App 20080076754 - Xiang; Min A. ; et al.	2008-03-27
Substituted Spiroheterocycles App 20080076753 - Xiang; Min A. ; et al.	2008-03-27
3,4-dihydro-2h-benzo[1,4]oxazine And Thiazine Derivatives As Cetp Inhibitors App 20070265252 - Kuo; Gee-Hong ; et al.	2007-11-15
1,2,3,4-tetrahydro-quinoline Derivatives As Cetp Inhibitors App 20070265304 - Rano; Thomas ; et al.	2007-11-15
Benzoazepin-oxy-acetic Acid Derivatives As Ppar-delta Agonists Used For The Increase Of Hdl-c, Lower Ldl-c And Lower Cholesterol App 20070244094 - Kuo; Gee-Hong ; et al.	2007-10-18
Method Of Use For Substituted Dipiperidine Ccr2 Antagonists App 20070219245 - Hou; Cuifen ; et al.	2007-09-20
Substituted Dipiperidine Ccr2 Antagonists App 20070197590 - DeMong; Duane E. ; et al.	2007-08-23
Substituted tetralins and indanes App 20060247314 - Chen; Xiaoli ; et al.	2006-11-02
Arylindenopyridines and related therapeutic and prophylactic methods App 20060154949 - Heintzelman; Geoffrey R. ; et al.	2006-07-13
Treating syndrome X with substituted tetralins and indanes App 20060094786 - Chen; Xiaoli ; et al.	2006-05-04
Methods of using substituted tetralins and indanes App 20060074130 - Chen; Xiaoli ; et al.	2006-04-06
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs App 20060058393 - DeAngelis; Alan ; et al.	2006-03-16
Arylindenopyridines and related therapeutic and prophylactic methods App 20050239782 - Heintzelman, Geoffrey R. ; et al.	2005-10-27
Methods of using peroxisome proliferator-activated receptor alpha target genes App 20050191668 - Zhou, Lubing ; et al.	2005-09-01
Arylindenopyridines and related therapeutic and prophylactic methods Grant 6,903,109 - Heintzelman , et al. June 7, 2	2005-06-07
Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators Grant 6,838,442 - Bussolari , et al. January 4, 2	2005-01-04
Treating Syndrome X with substituted tetralins and indanes App 20040171680 - Chen, Xiiaoli ; et al.	2004-09-02
Methods of using substituted tetralins and indanes App 20040167211 - Chen, Xiiaoli ; et al.	2004-08-26
Treating syndrome X with substituted tetralins and indanes App 20040162352 - Chen, Xiaoli ; et al.	2004-08-19
Arylindenopyridines and related therapeutic and prophylactic methods App 20040082578 - Heintzelman, Geoffrey R. ; et al.	2004-04-29
Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide Y modulators Grant 6,653,478 - Urbanski , et al. November 25, 2	2003-11-25
Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators App 20030199557 - Bussolari, Jacqueline C. ; et al.	2003-10-23
Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators App 20030195235 - Bussolari, Jacqueline C. ; et al.	2003-10-16
Novel substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide Y modulators App 20030073842 - Urbanski, Maud J. ; et al.	2003-04-17
Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators App 20030055091 - Bussolari, Jacqueline C. ; et al.	2003-03-20
Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators App 20030045553 - Bussolari, Jacqueline C. ; et al.	2003-03-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.